A. Bakhai

First name
Last name
Bakhai, A., Rigney, U., Hollis, S., & Emmas, C. (2012). Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.2308
Furuland, H., McEwan, P., Evans, M., Linde, C., Ayoubkhani, D., Bakhai, A., et al. (2018). Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink. BMC Nephrol. http://doi.org/10.1186/s12882-018-1007-1
Hill, N. R., Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., et al. (2019). Predicting atrial fibrillation in primary care using machine learning. PLoS One. http://doi.org/10.1371/journal.pone.0224582
Linde, C., Bakhai, A., Furuland, H., Evans, M., McEwan, P., Ayoubkhani, D., & Qin, L. (2019). Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.012655
Linde, C., Qin, L., Bakhai, A., Furuland, H., Evans, M., Ayoubkhani, D., et al. (2019). Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK. ESC Heart Fail. http://doi.org/10.1002/ehf2.12402
Bakhai, A., Petri, H., Vahidnia, F., Wolf, C., Ding, Y., Foskett, N., & Sculpher, M. (2020). Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England. J Eval Clin Pract. http://doi.org/10.1111/jep.13400
Banerjee, A., Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., et al. (2021). Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwaa155